4xwy
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='4xwy' size='340' side='right'caption='[[4xwy]], [[Resolution|resolution]] 2.35Å' scene=''> | <StructureSection load='4xwy' size='340' side='right'caption='[[4xwy]], [[Resolution|resolution]] 2.35Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4xwy]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4xwy]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XWY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XWY FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=43O:N-[2-(5-HYDROXY-2-METHYL-1H-INDOL-3-YL)ETHYL]-2-METHOXYACETAMIDE'>43O</scene>, <scene name='pdbligand=NDP:NADPH+DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NDP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=43O:N-[2-(5-HYDROXY-2-METHYL-1H-INDOL-3-YL)ETHYL]-2-METHOXYACETAMIDE'>43O</scene>, <scene name='pdbligand=NDP:NADPH+DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NDP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
- | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xwy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xwy OCA], [https://pdbe.org/4xwy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xwy RCSB], [https://www.ebi.ac.uk/pdbsum/4xwy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xwy ProSAT]</span></td></tr> | |
- | + | ||
- | + | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/SPRE_HUMAN SPRE_HUMAN] Defects in SPR are the cause of dystonia DOPA-responsive due to sepiapterin reductase deficiency (DRDSPRD) [MIM:[https://omim.org/entry/612716 612716]. In the majority of cases, patients manifest progressive psychomotor retardation, dystonia and spasticity. Cognitive anomalies are also often present. The disease is due to severe dopamine and serotonin deficiencies in the central nervous system caused by a defect in BH4 synthesis. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures.<ref>PMID:11443547</ref> <ref>PMID:16650784</ref> <ref>PMID:17159114</ref> |
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/SPRE_HUMAN SPRE_HUMAN] Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 27: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Gorszka | + | [[Category: Gorszka KI]] |
- | [[Category: Hovius | + | [[Category: Hovius R]] |
- | [[Category: Johnsson | + | [[Category: Johnsson K]] |
- | [[Category: Pojer | + | [[Category: Pojer F]] |
- | + | ||
- | + | ||
- | + |
Revision as of 17:55, 26 April 2023
Crystal structure of human sepiapterin reductase in complex with an N-acetylserotinin analogue
|